Submitted by Anonymous (not verified) on 9 October 2026 - 12:08
Human medicines European public assessment report (EPAR): Svariya (previously Rivaroxaban Koanaa), rivaroxaban, Date of authorisation: 21/11/2025, Revision: 3, Status: Authorised
Source: